SAN FRANCISCO--(BUSINESS WIRE)--Dec. 12, 2005--Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the introduction of iProtocol(TM), its latest technology and eScience contribution to the life sciences. Through a partnership with the global publisher John Wiley & Sons, Inc. (NYSE:JWa) (NYSE:JWb), scientists will have free access to selected Current Protocols(TM), which is the life science community’s gold standard for lab research manuals.
